Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
77 Cards in this Set
- Front
- Back
|
Abacavir (ABC, Ziagen) Indications
|
HIV Infection
|
|
|
Abacavir (ABC, Ziagen) Contraindications
|
Hepatic Impairment
|
|
|
Abacavir (ABC, Ziagen) Dosages
|
300mg PO bid
|
|
|
Didanosine (Videx) Indications
|
HIV Infection
|
|
|
Didanosine (Videx) Contraindications
|
None
|
|
|
Didanosine (Videx) Dosages
|
125-200mg PO q12h
|
|
|
Emtricitabine (Emtriva) Indications
|
HIV Infections
|
|
|
Emtricitabine (Emtriva) Contraindications
|
None
|
|
|
Emtricitabine (Emtriva) Dosages
|
200mg cap PO qd
|
|
|
Zidovudine (AZT, ZDV) Indications
|
Maternal-fetal HIV infection prevention, HIV infection
|
|
|
Zidovudine (AZT, ZDV) Contraindications
|
None
|
|
|
Zidovudine (AZT, ZDV) Dosages
|
100mg PO 5x/day or 300mg PO bid
|
|
|
Delavirdine (Rescriptor) Indications
|
HIV infection
|
|
|
Delavirdine (Rescriptor) Contraindications
|
None
|
|
|
Delavirdine (Rescriptor) Dosages
|
400mg PO tid
|
|
|
Efavirenz (Sustiva) Indications
|
HIV infection
|
|
|
Efavirenz (Sustiva) Contraindications
|
None
|
|
|
Efavirenz (Sustiva) Dosages
|
600mg PO qhs
|
|
|
Nevirapine (Viramune) Indications
|
HIV infection
|
|
|
Nevirapine (Viramune) Contraindications
|
Post-exposure prophylaxis use; Hepatic impairment, Child-Pugh Class Bor C; Baseline CD4 >250 (female pts); Baseline CD4>400 (male pts)
|
|
|
Nevirapine (Viramune) Dosages
|
200mg PO bid
|
|
|
Atazanavir (Reyataz) Indications
|
tx-naïve and td-experienced HIV infection
|
|
|
Atazanavir (Reyataz) Contraindications
|
pts<3mos; Hemodialysis, hepatic impairment (Child-Pugh Class C)
|
|
|
Atazanavir (Reyataz) Dosages
|
300-400mg PO qd
|
|
|
Darunavir (Prezista) Indications
|
tx-naïve and td-experienced HIV infection
|
|
|
Darunavir (Prezista) Contraindications
|
pts<3years old
|
|
|
Darunavir (Prezista) Dosages
|
800mg POqd
|
|
|
Fosamprenavir (Lexiva) Indications
|
HIV infection
|
|
|
Fosamprenavir (Lexiva) Contraindications
|
None
|
|
|
Fosamprenavir (Lexiva) Dosages
|
700-1400mg PO bid
|
|
|
Indinavir (Crixivan) Indications
|
HIV infection
|
|
|
Indinavir (Crixivan) Contraindications
|
None
|
|
|
Indinavir (Crixivan) Dosages
|
800mg PO q8h
|
|
|
Lopinavir/ritonavir (Kaletra) Indications
|
HIV infection
|
|
|
Lopinavir/ritonavir (Kaletra) Contraindications
|
Neonates <42 weeks postmenstrual age and <14 days old; Congenital QT syndrome; Hypokalemia
|
|
|
Lopinavir/ritonavir (Kaletra) Dosages
|
400mg/100mg PO bid
|
|
|
Nelfinavir (Viracept) Indications
|
HIV infection
|
|
|
Nelfinavir (Viracept) Contraindications
|
hepatic impairment, Child-Pugh Class B or C
|
|
|
Nelfinavir (Viracept) Dosages
|
750-1250mg PO bid
|
|
|
Ritonavir (Norvir) Indications
|
HIV infection
|
|
|
Ritonavir (Norvir) Contraindications
|
None
|
|
|
Ritonavir (Norvir) Dosages
|
300-600mg PO bid; 100mg PO bid q2-3 days
|
|
|
Saquinavir (Invirase) Indications
|
HIV infection
|
|
|
Saquinavir (Invirase) Contraindications
|
QT prolongation or history of QT prolongation; baseline
QTc>450msec; AV block without a pacemaker; cardiac conduction disturbance; cardiac structural abnormalities; cardiomyopathy; ischemic heart disease; hypokalemia; hypomagnesemia; severe hepatic impairment |
|
|
Saquinavir (Invirase) Dosages
|
1000mg PO bid
|
|
|
Tipranavir (Apitivus) Indications
|
HIV infection
|
|
|
Tipranavir (Apitivus) Contraindications
|
hepatic impairment, Child-Pugh Class B or C
|
|
|
Tipranavir (Apitivus) Dosages
|
500mg PO bid
|
|
|
Enfuvirtide (Fuzeon) Indications
|
HIV infection
|
|
|
Enfuvirtide (Fuzeon) Contraindications
|
None
|
|
|
Enfuvirtide (Fuzeon) Dosages
|
90mg SC bid
|
|
|
Maraviroc (Selzentry) Indications
|
CCR5-tropic HIV infection
|
|
|
Maraviroc (Selzentry) Contraindications
|
CXCR4-tropic or dual/mixed HIV infection; CrCl<30 and CYP3A strong inhibitor or inducer use
|
|
|
Maraviroc (Selzentry) Dosages
|
150-600mg PO bid
|
|
|
Raltegravir (Isentress) Indications
|
HIV infection
|
|
|
Raltegravir (Isentress) Contraindications
|
None
|
|
|
Raltegravir (Isentress) Dosages
|
400mg bid
|
|
|
Anthrax Vaccine Pre-exposure IM
|
0.5mL IM x5 at 0,1,6,12, and 18 months
|
|
|
Anthrax Vaccine Pre-exposure SC
|
0.5mL SC x6 at 0,2,4 weeks and then 6, 12, and 18 mo
|
|
|
Anthrax Vaccine Post-exposure:
|
0.5mL SC x3 at 0, 2, and 4 weeks
|
|
|
Anthrax Vaccine Contraindications
|
None
|
|
|
Diptheria/Tetanus toxiods and acellular pertussis/Poliovirus, Inactivated/Haemophilus b conjugate (PRP-T)
|
6wks – 4 years of age: 0.5mL IM q6-8wk x 3 doses, then 0.5mL IM at 15-18 mo
|
|
|
Diptheria/Tetanus Contraindications
|
encephalopathy within 7 days after pertussis vaccine;
neurologic disorder; infantile spasms; uncontrolled epilepsy; progressive encephalopathy |
|
|
Hep A (Havrix) Vaccine
|
1mL IM x2 doses 6-12 mo apart
|
|
|
Hep A (Havrix) Vaccine Contriandications
|
Hypersensitivity to neomycin
|
|
|
Hep B (Recombivax HB) <20 yo
|
5mcg IM x3 doses at 0, 1, 6 months
|
|
|
Hep B (Recombivax HB) >20 yo
|
10mcg IM x3 doses at 0, 1, 6 months; 40mcg for immunocompromised pt
|
|
|
Hep B (Recombivax HB) Contraindications
|
hypersensitivity to yeast
|
|
|
HPV (Cervarix)
|
18-25 yo females: 0.5mL IM x3 at 0, 1, 6 months
|
|
|
HPV (Cervarix) Contraindications
|
None
|
|
|
Japanese Encephalitis (Ixiaro)
|
0.5mL IM x2 doses 4wks apart
|
|
|
Japanese Encephalitis (Ixiaro) Contraindications
|
hypersensitivity to protamine sulfate
|
|
|
Measles/Mumps/Rubella (MMR II) >12mo
|
0.5mL SC x1 at 12-15 mos, then 0.5mL SC at 4-6 yo
|
|
|
Measles/Mumps/Rubella (MMR II) Adult
|
0.5mL SC x1-2
|
|
|
Menigococcal disease (Menveo)
|
18-55yo: 0.5mL IM x1
|
|
|
Pneumococcal (pneumovax 23)
|
0.5mL SC/IM x1
|
|
|
Pneumococcal (pneumovax 23) Contraindications
|
concurrent XRT
|
